BridgeMD
New treatment option for Kidney Transplant Recipients
Official title Velocity-Based Resistance Training in Kidney Transplant Recipients
ClinicalTrials.gov ID: NCT07370727
What this study is testing
- What it's testing
- This randomized controlled trial aims to evaluate the effects of velocity-based resistance training on renal function and metabolic health in kidney transplant recipients. Participants will be randomized into two groups performing resistance training at different execution velocities (maximal intended vs.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Men and women aged 18 to 50 years.
- Kidney transplant performed ≥12 months before enrollment.
- Stable graft function in the previous 6 months (serum creatinine \< 1.5 mg/dL, no rejection episodes).
- Written medical clearance from a nephrologist to perform moderate-to-vigorous physical activity.
- Signed informed consent.
You likely can't join if
- Active autoimmune disorders.
- Recent coronary disease (≤6 months).
- Severe musculoskeletal limitations incompatible with resistance training.
- Diagnosis of diabetes mellitus (pre- or post-transplant).
- Current active infection.
- Use of immunosuppressive drugs with contraindications for exercise (e.g., mTOR inhibitors at baseline).
The study team makes the final eligibility decision.
Where it's taking place
- Bogotá, Bogota D.C., Colombia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bogotá, Bogota D.C., Colombia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.